These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7104552)

  • 41. Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate.
    Goodnick PJ; Fieve RR; Schlegel A; Baxter N
    Am J Psychiatry; 1987 Mar; 144(3):367-9. PubMed ID: 3103474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants.
    Serretti A; Lorenzi C; Lilli R; Mandelli L; Pirovano A; Smeraldi E
    Am J Med Genet; 2002 May; 114(4):370-9. PubMed ID: 11992559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double blind comparison of lithium carbonate and ludiomil in the prophylaxis of unipolar affective illness.
    Coppen A; Gupta R; Montgomery S; Bailey J
    Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):94-9. PubMed ID: 790412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study.
    Maj M; Starace F; Nolfe G; Kemali D
    Pharmacopsychiatry; 1986 Nov; 19(6):420-3. PubMed ID: 3797469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Lithium in the prophylaxis of recurrent affective disorders. Effectiveness of low plasma levels and predictors to clinical response (author's transl)].
    Faravelli C; Marchetti G; Benvenuti P; Cabras PL
    Riv Patol Nerv Ment; 1980; 101(6):261-71. PubMed ID: 6801749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A possible antiviral action of lithium carbonate in herpes simplex virus infections.
    Amsterdam JD; Maislin G; Rybakowski J
    Biol Psychiatry; 1990 Feb; 27(4):447-53. PubMed ID: 2155671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lithium level and inter-episode symptoms in affective disorder.
    Goodnick PJ; Fieve RR; Schlegel A; Kaufman K
    Acta Psychiatr Scand; 1987 Jun; 75(6):601-3. PubMed ID: 3618281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate.
    Berrettini WH; Nurnberger JI; Hare TA; Simmons-Alling S; Gershon ES; Post RM
    Biol Psychiatry; 1983 Feb; 18(2):185-94. PubMed ID: 6403063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; 2001(2):CD003013. PubMed ID: 11406061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
    Meltzer HY
    Ann N Y Acad Sci; 1984; 430():115-37. PubMed ID: 6378031
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term therapy of affective disorders: monotherapy or polypharmacy?
    König W; Rissom R; Kalfoglu G; Stein A; Reimer F
    Pharmacopsychiatry; 1988 Nov; 21(6):272-3. PubMed ID: 3244749
    [No Abstract]   [Full Text] [Related]  

  • 52. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of lithium in patients treated with controlled release lithium formulations.
    Phillips JD; Myers DH; King JR; Armond AD; Derham C; Puranik A; Corbett JA; Birch NJ
    Int Clin Psychopharmacol; 1990 Jan; 5(1):65-9. PubMed ID: 2332609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lithium in bipolar and other affective disorders: prescribing practice in the UK.
    Paton C; Barnes TR; Shingleton-Smith A; McAllister-Williams RH; Kirkbride J; Jones PB; McIntyre S;
    J Psychopharmacol; 2010 Dec; 24(12):1739-46. PubMed ID: 20488832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dynamics of platelet serotonin levels in affective disorders].
    Karas' SI; Kornetov NA; Makarova EV; Sherina OL
    Biull Eksp Biol Med; 1994 Mar; 117(3):240-2. PubMed ID: 8204839
    [No Abstract]   [Full Text] [Related]  

  • 58. Prediction of lithium maintenance doses using a single point prediction protocol.
    Perry PJ; Prince RA; Alexander B; Dunner FJ
    J Clin Psychopharmacol; 1983 Feb; 3(1):13-7. PubMed ID: 6833518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A follow-up study on rapid cycling affective disorders].
    Liu ZZ; Mei QY; Wan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Sep; 20(3):335-7. PubMed ID: 2625345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tryptophan depletion in lithium-stabilized patients with affective disorder.
    Johnson L; El-Khoury A; Aberg-Wistedt A; Stain-Malmgren R; Mathé AA
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):329-36. PubMed ID: 11806858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.